Trial Profile
Radiofrequency ablation +/- irbesartan in patients with long-lasting persistent atrial fibrillation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2011
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 18 Apr 2011 New trial record
- 01 Apr 2011 Results published in the Annals of Thoracic Surgery.